Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1839]
News [4199]
Articles [376]
Editorials [10]
Conferences [104]
elearning [29]
Trastuzumab emtansine improves overall survival versus treatment of physician's...
Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium
Trastuzumab emtansine improves overall survival versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cance ( Prof Hans Wildiers - University Hospital of Leuven, Leuven, Belgium )
17 Dec 2015
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response...
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
Homologous recombination deficiency predicts neo-adjuvant chemotherapy response in triple-negative breast cancer ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy
Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX
TAILORx: Genomic test helps identify low-risk women who do not need chemotherapy ( Dr Virginia Kaklamani - UT Health Science Center, San Antonio, TX )
17 Dec 2015
Efficacy and gene expression results from eribulin SOLTI1007 neoadjuvant study
Dr Javier Cortes - Vall d´Hebron Institute of Oncology, Barcelona, Spain
Efficacy and gene expression results from eribulin SOLTI1007 neoadjuvant study ( Dr Javier Cortes - Vall d´Hebron Institute of Oncology, Barcelona, Spain )
17 Dec 2015
ER and FGFR1 interaction critical in endocrine resistant breast cancer
Dr Luigi Formisano - Vanderbilt University Nashville, USA
ER and FGFR1 interaction critical in endocrine resistant breast cancer ( Dr Luigi Formisano - Vanderbilt University Nashville, USA )
16 Dec 2015
Interrupting breast cancer treatment for young women who desire pregnancy
Dr Olivia Pagani and Dr Ann Partridge
Interrupting breast cancer treatment for young women who desire pregnancy ( Dr Olivia Pagani and Dr Ann Partridge )
16 Dec 2015
Editor's choice for December 2015
Prof Gordon McVie - ecancer Editor
Editor's choice for December 2015 ( Prof Gordon McVie - ecancer Editor )
16 Dec 2015
Treatment outcomes in patients with invasive breast cancer treated with...
Prof Jennifer De Los Santos - University of Alabama, Birmingham, USA
Treatment outcomes in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast MR imaging ( Prof Jennifer De Los Santos - University of Alabama, Birmingham, USA )
15 Dec 2015
Novel estrogen receptor-targeting agent represents ‘quantum leap’
Dr Ganesh Raj - UT Southwestern Medical Center, Dallas, USA
Novel estrogen receptor-targeting agent represents ‘quantum leap’ ( Dr Ganesh Raj - UT Southwestern Medical Center, Dallas, USA )
15 Dec 2015
Ductal carcinoma in situ: Anastrozole versus tamoxifen
Dr Terry Mamounas - UF Health Cancer Center, Orlando, USA
Ductal carcinoma in situ: Anastrozole versus tamoxifen ( Dr Terry Mamounas - UF Health Cancer Center, Orlando, USA )
15 Dec 2015
Update on management of the axilla
Dr Terry Mamounas - UF Health Cancer Center, Orlando, USA
Update on management of the axilla ( Dr Terry Mamounas - UF Health Cancer Center, Orlando, USA )
14 Dec 2015
Higher local recurrence after skin-sparing than simple mastectomy for DCIS
Prof Nigel Bundred, University of Manchester, Manchester, United Kingdom
Higher local recurrence after skin-sparing than simple mastectomy for DCIS ( Prof Nigel Bundred, University of Manchester, Manchester, United Kingdom )
14 Dec 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation